Moderna’s first-quarter revenue was slashed nearly in half over the course of a year as sales of its COVID-19 vaccine plunged. Related Content Even a new and improved COVID vaccine isn't budging Moderna stock Moderna is getting close to a norovirus vaccine Wegovy and Ozempic: Are we ready for weight loss drugs? CC Share Subtitles Off English Share this Video Facebook Twitter Email Reddit Link view video Wegovy and Ozempic: Are we ready for weight loss drugs? The company reported $167 million in